Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
BioVie Inc. logo

BioVie Inc. (BIVIW) Stock Ticker

NASDAQ: BIVIW · Healthcare · Biotechnology
$0.2999-0.03%
USD · as of 2026-09-28 · market cap $2.6M
Open BIVIW in TickrDownload for iPhone

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full BIVIW picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on BIVIW
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About BioVie Inc.

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. It also develops Bezisterim, an investigational, novel, orally administered small molecule that is In Phase 3 clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2b clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

BIVIW stock facts

Ticker symbolBIVIW
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Market cap$2.6M
CEOCuong Viet Do
Employees13
HeadquartersCarson City, NV, US
IPO date2026-07-17
Websitewww.bioviepharma.com

What you can see for BIVIW on Tickr

Live BIVIW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BIVIW report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for BioVie Inc.?

The ticker symbol for BioVie Inc. is BIVIW, listed on the NASDAQ.

What is BIVIW?

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. It also develops…

HomeExploreMarketLists
All pages